Publications

Urban AM, Gaffney SH, McCarthy L, Hollins DM, Abelmann A, Unice K, Liong M, Finley BL, Henshaw JL. Volatile organic compounds released from spreading ground coffee during a simulated industrial task. Poster presentation at Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Pierce JS, Abelmann A, Lotter J, Comerford C, Keeton K, Finley BL. Characterization of diacetyl exposures associated with the preparation and consumption of unflavored coffee. Poster presentation at Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Glynn ME, Adams RE, Beckett EM, Pierce JS, Scott PK, Finley BL. Derivation of a human equivalent concentration for chronic inflammation in the bronchial and bronchiolar epithelium of the lung following inhalation exposure to diacetyl. Poster presentation at Society of Toxicology 54^th Annual Meeting, 2015.

Cowan DM, Maskrey JR, Fung E, Woods T, Stabryla L, Scott PK, Finley BL. Evaluation of empirically-based PBPK modeling approaches for modeling ante- and post mortem ethanol concentrations in biological matrices. Poster presentation Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. Toxicology based cancer causation analysis of COCR-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. Poster presentation at Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Beckett EM, Glynn ME, Adams RE, Pierce JS, Scott PK, Finley BL. Refined derivation of a human equivalent concentration for hyperplasia of bronchiolar epithelium following airborne diacetyl exposure. Poster presentation at Society of Toxicology 54^th Annual Meeting, San Diego, CA, 2015.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol 34(9):939–967.

Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570.

Finley BL, Scott PK. 2014. Diacetyl and “popcorn lung” litigation: Assessing the evidence for general causation. ABA Environ Litigation Toxic Torts Newsletter 15(2):7–10.

Kerger BD, Thuett KA, Finley BL. 2014. Evaluation of four a-diketones for toll-like receptor-4 (TLR-4) activation in a human transfected cell line. Food Chem Toxicol 74:117–119.

Paustenbach DJ, Galbraith DA, Finley BL. 2014. Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(2):98–112; doi: 10.3109/15563650.2013.857024. PMID: 24256093.

Pierce JS, Abelmann A, SpicerLJ, Adams RE, Finley BL. 2014. Diacetyl and 2,3-pentanedione exposures associated with cigarette smoking: Implications for risk assessment of food and flavoring workers. Crit Rev Toxicol 44(5):420–435; doi: 10.3109/10408444.2014.882292. PMID: 24635357.

Unice KM, Kerger BD, Paustenbach DJ, Finley BL, Tvermoes BE. 2014. Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. Chem-Biol Interact 216:53–74; doi: 10.1016/j.cbi.2014.04.001. PMID: 24726710.

Monnot AD, Christian WV, Paustenbach DJ, Finley BL. 2014. Correlation of blood Cr(III) and adverse health effects: Application of PBPK modeling to determine non-toxic blood concentrations. Crit Rev Toxicol 44(7):618–637; doi:10.3109/10408444.2014.926472. PMID: 25068491.

Tvermoes BE, Unice KM, Paustenbach DJ, Finley BL, Otani JM, Galbraith DA. 2014. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d1-3. Am J Clin Nutr 99(3):632–646; doi: 10.3945/ajcn.113.071449. PMID: 24500148.

Tvermoes BE, Finley BL, Unice KM, Otani JM, Paustenbach DJ, Galbraith DA. 2013. Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food Chem Toxicol 53:432–439; doi: 10.1016/j.fct.2012.11.033. PMID: 23207477.

Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL, Kerger BD. 2013. A review of the health hazards posed by cobalt. Crit Rev Toxicol 43(4):316–362; doi:10.3109/10408444.2013.779633. PMID: 23656559.

Kerger BD, Tvermoes BE, Unice KM, Finley BL, Paustenbach DJ, Galbraith DA. 2013. Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt (II) chloride dietary supplement for 90 days. Toxicol Environ Chem 95(4):709–718; doi: 10.1080/02772248.2013.792559.

Kerger BD, Gerads R, Gurleyuk H, Thuett KA, Finley BL, Paustenbach DJ. 2013. Cobalt speciation assay for human serum, Part I. Method for measuring large and small molecular cobalt and protein-binding capacity using size exclusion chromatography with inductively-coupled plasma-mass spectroscopy detection. Toxicol Environ Chem 95(4):687–708; doi: 10.1080/02772248.2013.793444.

Finley BL, Unice KM, Kerger BD, Otani JM, Paustenbach DJ, Galbraith DA, Tvermoes BE. 2013. 31-day study of cobalt (II) chloride ingestion in humans: Pharmacokinetics and clinical effects. J Toxicol Environ Health A, 76:1210–1224; doi: 10.1080/15287394.2013.848391. PMID: 24283372.